Table 4.
Characteristics of inhaled corticosteroid and long acting beta-agonist combination inhalers
| Class | Drug | Brand name | Delivery device | Delivery device name | Dose (µg) | Frequency |
|---|---|---|---|---|---|---|
| ICS/LABA | Fluticasone Propionate/Salmeterol | Seretide | DPI | Accuhaler | 500/50 | Twice daily |
| ICS/LABA | Budesonide/Formoterol | Symbicort | DPI | Turbohaler | 400/12 | Twice daily |
| ICS/LABA | Budesonide/Formoterol | DuoResp Spiromax | DPI | 400/12 | Twice daily | |
| ICS/LABA | Fluticasone Furoate/Vilanterol | Relvar | DPI | Ellipta | 92/22 | Once daily |
| ICS/LABA | Beclometasone/Formoterol | Fostair | pMDI | pMDI | 200/12 | Twice daily |
pMDI, pressurized metered dose inhaler; ICS, inhaled corticosteroid; LABA, long acting beta-agonist; DPI, dry powder inhaler.